Literature DB >> 33656920

Human Colonization with Extended-Spectrum Beta-Lactamase-Producing E. coli in Relation to Animal and Environmental Exposures in Bangladesh: An Observational One Health Study.

Emily K Rousham1, Muhammad Asaduzzaman2, T I M Amin Uddin Mozmader3, Mohammed Badrul Amin3, Mahdia Rahman3, Muhammed Iqbal Hossain3, Md Rayhanul Islam3, Zahid Hayat Mahmud3, Leanne Unicomb3, Mohammad Aminul Islam4.   

Abstract

BACKGROUND: Human exposure to intensively farmed livestock is a potential risk for transmission of antibiotic-resistant bacteria (ARB) but few studies have assessed the relative role of animal vs. environmental sources of ARB in low-resource community settings.
OBJECTIVES: We conducted an observational study to compare ARB colonization and antibiotic-resistant gene prevalence and abundance in humans with high or low exposure to poultry in rural households, commercial poultry farms, and urban markets in Bangladesh.
METHODS: Extended-spectrum β-lactamase (ESBL)-producing and carbapenem-resistant E. coli were quantified in feces from adults with high or low poultry exposure (n=100, respectively), poultry (n=200), drinking water (n=120), and wastewater (n=120) from 40 rural households, 40 poultry farms, and 40 urban markets.
RESULTS: ESBL-producing E. coli (ESBL-EC) prevalence was 67.5% (95% CI: 61.0, 74.0) in samples from adults, 68.0% (95% CI: 61.5, 74.5) in samples from poultry, and 92.5% (95% CI: 87.7, 97.3) in wastewater samples. Carbapenem-resistant E. coli prevalence was high in market wastewaters [30% (95% CI: 15.0, 45.0)] but low in humans (1%) and poultry (1%). Human, poultry, and wastewater isolates shared common resistance genes: blaCTX-M-1, qnr, and blaTEM. Human colonization was not significantly associated with exposure to poultry or setting (rural, farm, or market). Ninety-five percent of commercial poultry farms routinely administered antibiotics. Susceptibility tests were significantly different in household vs. farm and market poultry isolates for four of seven antibiotic classes. In human isolates, there were no differences except aminoglycoside resistance (16.4% high vs. 4.4% low exposure, p=0.02). Urban market wastewaters and poultry samples had significantly higher concentrations of ESBL-EC (p<0.001) and blaCTX-M-1 (p<0.001) compared with samples from farms and rural households. DISCUSSION: ESBL-EC colonization was high in humans but not significantly associated with exposure to poultry. Bidirectional transmission of antibiotic resistance is likely between humans, poultry, and the environment in these community settings, underlining the importance of One Health mitigation strategies. https://doi.org/10.1289/EHP7670.

Entities:  

Year:  2021        PMID: 33656920     DOI: 10.1289/EHP7670

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  3 in total

1.  Understanding transmission pathways and integrated digital surveillance potential of antimicrobial resistance in Ethiopia in a One Health approach: a mixed-method study protocol.

Authors:  Muhammad Asaduzzaman; Ernst Kristian Rodland; Zeleke Mekonnen; Christoph Gradmann; Andrea Sylvia Winkler
Journal:  BMJ Open       Date:  2022-06-09       Impact factor: 3.006

2.  High prevalence of plasmid-mediated quinolone resistance (PMQR) among E. coli from aquatic environments in Bangladesh.

Authors:  Mohammed Badrul Amin; Sumita Rani Saha; Md Rayhanul Islam; S M Arefeen Haider; Muhammed Iqbal Hossain; A S M Homaun Kabir Chowdhury; Emily K Rousham; Mohammad Aminul Islam
Journal:  PLoS One       Date:  2021-12-29       Impact factor: 3.240

3.  Antibiotic usage practices and its drivers in commercial chicken production in Bangladesh.

Authors:  Sukanta Chowdhury; Guillaume Fournié; Damer Blake; Joerg Henning; Patricia Conway; Md Ahasanul Hoque; Sumon Ghosh; Shahana Parveen; Paritosh Kumar Biswas; Zubair Akhtar; Khaleda Islam; Md Ariful Islam; Md Mahbubur Rashid; Ludvic Pelligand; Zobaidul Haque Khan; Mahmudur Rahman; Fiona Tomley; Nitish Debnath; Fahmida Chowdhury
Journal:  PLoS One       Date:  2022-10-17       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.